R. D. Foord

654 total citations
15 papers, 493 citations indexed

About

R. D. Foord is a scholar working on Pharmacology, Oncology and Pharmacology. According to data from OpenAlex, R. D. Foord has authored 15 papers receiving a total of 493 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 4 papers in Oncology and 4 papers in Pharmacology. Recurrent topics in R. D. Foord's work include Antibiotics Pharmacokinetics and Efficacy (8 papers), Drug Transport and Resistance Mechanisms (4 papers) and Antibiotic Resistance in Bacteria (4 papers). R. D. Foord is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (8 papers), Drug Transport and Resistance Mechanisms (4 papers) and Antibiotic Resistance in Bacteria (4 papers). R. D. Foord collaborates with scholars based in United States, Canada and United Kingdom. R. D. Foord's co-authors include Michael Dodds, Stephen T. Holgate, G. D. Phillips, D. M. Ryan, P. W. Muggleton, R. B. Sykes, Cynthia H. O'Callaghan, A. M. Joekes, Ragnar Norrby and R Gabriel and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Antimicrobial Agents and Chemotherapy and British Journal of Pharmacology.

In The Last Decade

R. D. Foord

15 papers receiving 382 citations

Peers

R. D. Foord
Martin E. Plaut United States
R. A. Walstad Norway
Stuart A. Kleit United States
R. Rohwedder Germany
Sou-Yie Chu United States
C. H. Dash United Kingdom
K. Sack Germany
Barbara O’Brien United States
R. van Dalen Netherlands
Y. Valcke Belgium
Martin E. Plaut United States
R. D. Foord
Citations per year, relative to R. D. Foord R. D. Foord (= 1×) peers Martin E. Plaut

Countries citing papers authored by R. D. Foord

Since Specialization
Citations

This map shows the geographic impact of R. D. Foord's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. D. Foord with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. D. Foord more than expected).

Fields of papers citing papers by R. D. Foord

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. D. Foord. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. D. Foord. The network helps show where R. D. Foord may publish in the future.

Co-authorship network of co-authors of R. D. Foord

This figure shows the co-authorship network connecting the top 25 collaborators of R. D. Foord. A scholar is included among the top collaborators of R. D. Foord based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. D. Foord. R. D. Foord is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Phillips, G. D., R. D. Foord, & Stephen T. Holgate. (1989). Inhaled lysine-aspirin as a bronchoprovocation procedure in aspirin-sensitive asthma: Its repeatability, absence of a late-phase reaction, and the role of histamine. Journal of Allergy and Clinical Immunology. 84(2). 232–241. 61 indexed citations
2.
Foord, R. D.. (1983). Ceftazidime: aspects of efficacy and tolerance. Journal of Antimicrobial Chemotherapy. 12(suppl A). 399–403. 13 indexed citations
3.
Atkinson, R. M., et al.. (1980). Effect of the timing of cefuroxime dosage on its protection of rats against gentamicin nephrotoxicity. Infection. 8(1). 41–42. 2 indexed citations
4.
Atkinson, R. M., et al.. (1977). The Toxicology of Cefuroxime. Proceedings of the Royal Society of Medicine. 70(9_suppl). 11–18. 8 indexed citations
5.
Norrby, Ragnar, R. D. Foord, J. D. Price, & Per Olov Hedlund. (1977). Pharmacokinetic and Clinical Studies on Cefuroxime. Proceedings of the Royal Society of Medicine. 70(9_suppl). 25–33. 19 indexed citations
6.
O'Callaghan, Cynthia H., R. B. Sykes, D. M. Ryan, R. D. Foord, & P. W. Muggleton. (1976). Cefuroxime - A new cephalosporin antibiotic.. The Journal of Antibiotics. 29(1). 29–37. 80 indexed citations
7.
Foord, R. D.. (1976). Cefuroxime: Human Pharmacokinetics. Antimicrobial Agents and Chemotherapy. 9(5). 741–747. 155 indexed citations
8.
Foord, R. D.. (1975). Cephaloridine, cephalothin and the kidney. Journal of Antimicrobial Chemotherapy. 1(suppl 3). 119–133. 66 indexed citations
9.
Mullinger, Brenda & R. D. Foord. (1974). Cephalexin and Oxytetracycline Compared by Double-Blind Trial in the Treatment of Bronchitis in General Practice. Current Medical Research and Opinion. 2(6). 356–365. 1 indexed citations
10.
Johnson, Susan E. & R. D. Foord. (1972). Cephalexin dosage in general practice assessed by double-blind trial. Current Medical Research and Opinion. 1(1). 37–48. 3 indexed citations
11.
Foord, R. D.. (1971). Nephrotoxicity of cephaloridine.. BMJ. 4(5785). 493–493. 9 indexed citations
12.
Gabriel, R, R. D. Foord, & A. M. Joekes. (1970). Reversible encephalopathy and acute renal failure after cephaloridine.. BMJ. 4(5730). 283–284. 15 indexed citations
13.
Dodds, Michael & R. D. Foord. (1970). Enhancement by potent diuretics of renal tubular necrosis induced by cephaloridine. British Journal of Pharmacology. 40(2). 227–236. 53 indexed citations
14.
Foord, R. D., et al.. (1964). Controlled clinical trial of 4-4 diisoamyloxythiocarbanilide in the treatment of pulmonary tuberculosis. Tubercle. 45(3). 192–201. 7 indexed citations
15.
Foord, R. D. & H. M. Gilles. (1959). Small Outbreak of Bornholm Disease in the Gambia. BMJ. 1(5125). 834–835. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martin E. Plaut Breakdown of academic impact, for papers by R. A. Walstad Breakdown of academic impact, for papers by Stuart A. Kleit Breakdown of academic impact, for papers by R. Rohwedder Breakdown of academic impact, for papers by Sou-Yie Chu Breakdown of academic impact, for papers by C. H. Dash Breakdown of academic impact, for papers by K. Sack Breakdown of academic impact, for papers by Barbara O’Brien Breakdown of academic impact, for papers by R. van Dalen Breakdown of academic impact, for papers by Y. Valcke
Rankless by CCL
2026